October 31, 2023
October 31, 2023 - The U.S. Food and Drug Administration has approved Wezlana (ustekinumab-auub) as a
biosimilar to and interchangeable with Stelara (ustekinumab)
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Medical Assistance
October 26, 2023
October 26, 2023 - Catalyst Pharmaceuticals, Inc. has reported that Santhera Pharmaceuticals has
obtained U.S. Food and Drug Administration ("FDA") approval for Agamree®
October 26, 2023
October 26, 2023 - Eli Lilly and Company has announced today that the U.S. Food and Drug Administration
(FDA) has approved OmvohTM (mirikizumab-mrkz)
October 25, 2023
October 25, 2023 - Exela Pharma Sciences, LLC, (Exela) is voluntarily recalling the products listed in the
table below to the consumer level. Particulate matter
October 23, 2023
October 23, 2023 - Celltrion USA has announced that the U.S. Food and Drug Administration (FDA) has
approved Zymfentra (infliximab-dyyb) for maintenance therapy
October 22, 2023
October 22, 2023 - Botanical-Be is voluntarily recalling all lots of Kuka Flex Forte Capsules, Artri King,
Capsules, and Reumo Flex Capsules to the consumer level.
October 20, 2023
October 20, 2023 - Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has
approved PenbrayaTM
October 20, 2023
FDA Approves Zituvio (sitagliptin) for the Treatment of Adult Patients with Type 2 Diabetes Mellitus
October 20, 2023 - Zydus Lifesciences has announced that the U.S. Food and Drug Administration (FDA)
approved its New Drug Application (NDA) for Zituvio (Sitagliptin) tablets